Effect of a single dose of methyl prednisolone as rescue medication for patients who develop hypotensive dengue shock syndrome during the febrile phase: a retrospective observational study
The dengue fever (DF) epidemic in 2009 in Sri Lanka resulted in nearly 370 deaths (1.4% case fatality), mainly adults. 1 Although dengue shock syndrome (DSS) is thought to occur during the immediate afebrile phase of dengue infection, we encountered adult patients developing hypotensive DSS during the febrile phase. Although steroids have been shown to decrease cell infection rates and inhibit pro-inflammatory cytokines, 2,3 existing data do not recommend routine use of steroids in the management of DF. 4 However, due to the higher-than-usual mortality during the current epidemic here, many clinicians used steroids empirically, usually as rescue medication. Studies that have assessed the effects of steroids in DF have all been in children. 5 Some show no benefit in established DSS, 6, 7 while two have shown benefits with high-dose methyl prednisolone. 8, 9 A possible role for steroids in complicated adult DF has not been investigated.
The management of dengue patients in our hospital in 2009 was based on the World Health Organization protocol, and regular meetings and audits were carried out in order to maintain uniform standards of care across medical units. In our unit a single dose of intravenous methyl prednisolone 1 g intravenous over 20 min was given as rescue medication to highly selected patients who developed hypotensive DSS (supine systolic blood pressure <100 mmHg and a postural drop of !20 mmHg with a pulse pressure 20 mmHg together with the presence of or rapidly developing ascites or pleural effusions and peripheral vascular collapse 10 ) during the febrile phase (with no evidence of secondary bacterial infection), in addition to the currently recommended management. Clinical and management data of 23 such patients (group A) were retrospectively compared with 32 comparable patients from other units who did not receive methyl prednisolone (group B). The groups were comparable with regard to age, sex, duration of illness, and clinical and laboratory parameters at the time of admission and when hypotensive DSS was detected ( 
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International Journal of Infectious Diseases j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / i j i d colloids, fresh frozen plasma, and platelets) compared to group A. In survivors, the mean time to hemodynamic stability in group A was 5.8 h compared to 18.2 h in group B. These preliminary observations seem to suggest that a timely single dose of intravenous methyl prednisolone may benefit adult patients who develop hypotensive DSS during the febrile phase of DF. We recommend randomized clinical trials to address this issue.
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